Mode of action of dipyridamole on human platelets.
D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects*; D002462:Cell Membrane / Q000201:enzymology; D000242:Cyclic AMP; D006152:Cyclic GMP; D004176:Dipyridamole / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D011464:Epoprostenol / Q000494:pharmacology; D006801:Humans; D008315:Malondialdehyde / Q000096:biosynthesis; D010974:Platelet Aggregation / Q000187:drug effects; D013929:Thromboxane B2 / Q000096:biosynthesis; D013997:Time Factors
D008315:Malondialdehyde; D013929:Thromboxane B2; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D011464:Epoprostenol; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000262:Adenylyl Cyclases; D006152:Cyclic GMP; D004837:Epinephrine